Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug
Provides Tetra with stable supply of high-quality ingredients and regulatory-approved services to satisfy clinical trials and prescription products Diversifies Akanda into cancer pain medical market as a specialized manufacturer of cannabis-based drugs for use in FDA clinical trials and pharmaceutical markets LONDON & MONTREAL–(BUSINESS WIRE)–Akanda Corp. (“Akanda”) (NASDAQ: AKAN)... Read more
InterCure and Clever Leaves Announce International Strategic Partnership
Ryan Allway March 22nd, 2022 News, Top News Leading global cannabis companies InterCure and Clever Leaves partner together to cultivate, market, and distribute pharmaceutical-grade medical cannabis in the EU, Australia and Israel NEW YORK and TORONTO, and HERZLIYA, Israel, March 22, 2022 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX:... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )